Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsBetty M. Tijms, Pieter Jelle Visser, Johan Gobom et al.|Brain|2020Cited by 221
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Frank Jessen, Axel Rominger et al.|The Lancet Neurology|2013Cited by 185
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J. Jansen, Vincent Mok, José Luís Molinuevo et al.|JAMA Psychiatry|2017Cited by 148
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Oliver Peters, Colin Groot et al.|Alzheimer s & Dementia|2018Cited by 91